Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis
Longitudinal comparative analysis of antidepressants and anti-anxiety medications in Alzheimer’s and Parkinson’s diseases: insights from French and British health records